Covid 19 treatment

Merck asks EU regulator to authorize its COVID-19 pill

Earlier this month, Britain became the first country in the world to OK the drug. The U.K. licensed molnupiravir for adults diagnosed with COVID-19 and with at least one risk factor for severe disease

published on : 23rd November 2021

Tiny antibodies from llamas can potentially treat COVID-19: Study

Researchers at the Rosalind Franklin Institute in the UK found that nanobodies -- a smaller, simple form of antibody -- can effectively target the SARS-CoV-2 virus.

published on : 22nd September 2021

Hetero's Tocilizumab biosimilar gets emergency use authorisation from DCGI for COVID treatment

Hetero's biologics arm, Hetero Biopharma will manufacture the drug at its dedicated biologics facility, based at Jadcherla in Hyderabad.

published on : 6th September 2021